| 34) Myint PK (2006) | The EPIC-Norfolk Study | 24,312 subjects (10,972 men and 13,340 women) aged 40-79, and without stroke. (UK) | 8.5 (1993-97 to 2004) | 217 men, and 204 women | Stroke incidence (mortality and hospital episodes) | Fish roe (fish roe and taramasalata) |
| Men | Women |
| RR = 1.13 (0.63-2.03; P = 0.69) for consumption vs no consumption.
|
RR = 1.34 (0.74-2.41; P = 0.34) for consumption vs no consumption.
|
Age, systolic blood pressure, BMI, smoking, cholesterol, diabetes, fish oil supplements, physical activity, alcohol consumption and total energy intake. |
| 33) Takachi R (2010) | The JPHC Study | 77,500 subjects (35,730 men and 41,770 women) aged 45-74, and without a history of cancer, CHD, or stroke. (Japan) | 1995-98 to 2004 | 1,745 | Stroke risk | Salted fish roe (tarako [salted Alaska pollack roe] or suziko [salted salmon roe]; 4.6-4.8% salt) |
HR = 1.14 (0.97-1.34; P = 0.09) for the highest vs lowest quintile of consumption.
Amount specific data (g):
0.0: HR = 1.
0.2: HR = 1.05 (0.87-1.27).
0.7: HR = 1.02 (0.86-1.21).
1.6: HR = 1.08 (0.91-1.28).
4.7: HR = 1.14 (0.97-1.34).
Effect modification: No significant interaction was found with sex, smoking status, age, cohort (I or II), BMI, or alcohol intake (no data shown). | Sex, age, BMI, smoking status, alcohol, physical activity, and energy, potassium, and calcium. |
|